Product Program year 2025 Source: CMS Open Payments

Mo.Ma Ultra

Device Embolic Protection Devices

PDI 08033477071909

Open in the dashboard

General payments

$101,586

612 payments

Research payments

$0

0 payments

Through program year 2025, $101,586 in general payments and $0 in research payments were reported against Mo.Ma Ultra (Embolic Protection Devices).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $66,027 508
2024 General $18,565 18
2023 General $8,717 25
2022 General $8,278 61

Breakdown

Who paid General payments · program years 2022–2025
  1. Medtronic, Inc. $101,586 612 payments
Top recipients General payments · program year 2025
  1. Mathew Wooster Vascular Surgery · West Columbia, SC $3,800 6% · 1 payment
  2. David Stewart Interventional Cardiology · Chicago, IL $2,897 4% · 18 payments
  3. William Gray Interventional Cardiology · Wynnewood, PA $2,589 4% · 17 payments
  4. Jacqueline Majors Vascular Surgery · Southaven, MS $2,443 4% · 11 payments
  5. Eric Scott Vascular Surgery · West Des Moines, IA $2,021 3% · 7 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $23,515 36% · 35 practitioners
  2. Interventional Cardiology Internal Medicine $20,451 31% · 20 practitioners
  3. Cardiovascular Disease Internal Medicine $7,964 12% · 12 practitioners
  4. Vascular & Interventional Radiology Radiology $5,881 9% · 18 practitioners
  5. Neurological Surgery $2,872 4% · 3 practitioners

The top 5 of 15 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Indiana $5,615 9% · 4 recipients
  2. Tennessee $4,862 7% · 3 recipients
  3. California $4,465 7% · 4 recipients
  4. North Carolina $4,265 6% · 8 recipients
  5. South Carolina $4,239 6% · 2 recipients

The top 5 of 31 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

612 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record